EntSun News

Popular on EntSun


Similar on EntSun

OLENPHOGY Targets "Hormonal Exhaustion" with Advanced 40:1 Inositol

EntSun News/11100519
Precision formula optimizes cellular repair for total endocrine restoratio

BRANDON, Fla. - EntSun -- OLENPHOGY announced its 40:1 Myo & D-Chiro Inositol complex, specifically designed to address "hormonal exhaustion"—a common state of fatigue, cycle irregularity, and brain fog caused by modern chronic stress and endocrine disruption.

Unlike standard supplements that only offer superficial relief, OLENPHOGY's formula provides targeted cellular restoration. By featuring the clinically recognized 40:1 ratio of Myo-Inositol (2,000mg) to D-Chiro-Inositol (50mg), the complex restores natural cellular insulin sensitivity and supports healthy ovarian function.

To counteract stress-driven hormone imbalances, the advanced blend includes key synergistic actives:
  • Ashwagandha Extract (5% Withanolides): Actively regulates cortisol levels and soothes emotional fatigue.
  • High-Bioavailability Nutrients: Combines Vitamin D3 (30mcg), L-5-MTHF Active Folate, and Chromium Picolinate (200mcg) for optimal metabolic repair and cellular division.
"True wellness requires addressing root metabolic signals rather than managing symptoms," said Dr. Marcus Lin, Director of Clinical Research. "Our multi-action inositol complex delivers the exact biochemical tools needed to reset endocrine balance."

More on EntSun News
For more information, visit: https://olenphogy.com/products/myo-d-chiro-inositol-40-1

About OLENPHOGY: OLENPHOGY is a U.S.-based premium wellness brand dedicated to smarter, precision-driven supplementation. Built on the principles of science, purity, precision, and efficiency, the brand develops clinically inspired formulas manufactured in cGMP-compliant facilities and validated through multi-stage quality testing to support intentional, informed wellness living.

Contact
Attn: PR Manager Hebe Lee
Email: hello@olenphogy.com
Phone: +1-888-588-6536
Website: https://olenphogy.com

Source: OLENPHOGY

Show All News | Disclaimer | Report Violation

0 Comments

Latest on EntSun News